$34.81
$0.13
(0.37%)
Quote as of 4:02 PM EST on 02/09/12
Charles River Laboratories
NYSE:CRL
Extended Hours:
$34.81
$0.00
(0.00%)
Quote as of 4:27 PM EST on 02/09/12 (NYSE)
|
$34.81
$0.13
(0.37%)
|
|
| Today's Open | $34.71 |
|---|---|
| Previous Close | $34.68 |
| Daily Range | $34.50 - $35.24 |
| 52-Week Range | $25.52 - $42.84 |
| Market Cap | $1.72B |
| P/E Ratio | -9.37 |
| Dividend (Yield) | $0.00 (0.0%) |
| Volume | 373,368 |
| Average Daily Volume | 555,635 |
| Current FY EPS | $2.43 |
CRL Information
| Description |
|---|
| Charles River supports early-stage drug development with a “research models” business that breeds lab rats and “preclinical services” that run clinical trials for pharma and biotech companies. |
| Sector |
| Healthcare |
| Industry |
| Life Sciences Tools and Services |
News & Commentary
Novo Nordisk Posts Solid 4Q - Analyst Blog
Why Drug Development Company Charles River Laboratories Is Undervalued
Why Charles River Laboratories International May Be About to Take Off
MannKind Treads the Neutral Path - Analyst Blog
Bristol-Myers/AstraZeneca get CRL - Analyst Blog
Company News for January 11, 2012 - Corporate Summary
Charles River Shares Soared: What You Need to Know
Arena Pharma Files Response to CRL - Analyst Blog
Charles River Guides Higher - Analyst Blog
Don't Get Too Worked Up Over ICON's Earnings
